Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Brainchip (ASX:BRN) share price on watch after FY21 report

The Brainchip Holdings Ltd (ASX: BRN) share price will be front and centre today after announcing its FY21 financial result overnight.

Keep up to date with the February 2022 reporting season calendar.

Unlike most ASX shares, Brainchip reports on a January 1 to December 31 financial year.

BrainChip has created a neuromorphic processing chip, which allegedly mimics the human brain (hence the name BrainChip) in artificial intelligence applications.

Brainchip share price on watch after FY21 report

Key financial results for the year ending 31 December include:

  • Revenue of $1.6 million, up from $0.2 million in FY20
  • Expenses of $21.2 million, increasing 89% year-on-year
  • Loss of $20.9 million, down from $26.8 million in FY20

The Brainchip share price achieved several milestones over the past year.

Ten patents were approved. Manufacturing partnerships were established. And the company welcomed a new CEO.

But the biggest step forward was the shift from concept to product.

The company began shipping development kits to prospective customers of its proprietary Akida chip.

“Most significantly, it was the year that BrainChip evolved from an R&D company into a company that supplies breakthrough edge AI technology to markets like automotive, transportation, aerospace, healthcare, and industrial IoT”

It’s important to remember the testing kits do not guarantee new customers and revenue.

Testing kits are merely a way of showing customers what the chip could do.

But it’s a notable step in Brainchip moving from an idea towards an investable business.

If and when the company announces customer contracts, that will validate the use case of the technology and lead to an uplift in revenue.

Capital raising likely in 2022

Brainchip’s share price of $1.26 implies it’s worth over $2.1 billion.

That’s plenty of blue sky for a business that is recording just $1.6 million in revenue.

But Brainchip remains loss-making, meaning it spends more than it receives in revenue.

With just $19.3 million of cash, the business will likely need to raise more capital from investors.

Assuming the current burn rate, Brainchip will require a cash injection at some point in 2022.

Overall, the FY21 report didn’t provide much more colour on the business.

Rather, it summarised the progress Brainchip has made over the past year and how it’s positioned going into 2022.

Given it still has no material revenue and the massive expectations baked into the Brainchip share price, I’m avoiding the business for now.

But if you’re looking for share ideas, check out 22 ASX shares I’m excited about it 2022.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report — or get it emailed to you — for FREE by CLICKING HERE NOW or the button below.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content